Pure Global
NCT06347315

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment (COGNIKET-MCI)

COGNIKET-MCI Trial: A Prospective, Randomized, Double-blind, Placebo-controlled, Multi-center, Multi-country, Pivotal Trial to Study the Effects of a Nutritional Intervention of Ketogenic Medium-chain Triglycerides (kMCT) and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive Impairment
Société des Produits Nestlé (SPN)·ClinicalTrials.gov·dietary supplementNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Mild Cognitive Impairment
Drug/Device/Intervention
BrainXpert
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
Société des Produits Nestlé (SPN)
Timeline & enrollment
Phase
N/A
Start date
May 10, 2024
End date
Dec 15, 2027
Enrollment
380 participants
Primary outcome

Preclinical Alzheimer's Cognitive Composite (PACC) score

Summary

Evaluation of the Effects of a Nutritional Intervention of Ketogenic Medium-chain
 Triglycerides and B-vitamins on Cognitive Functioning in Older Adults With Mild Cognitive
 Impairment (COGNIKET-MCI)

ICD-10 classifications
Mild cognitive disorderAlzheimer diseaseDementia in other specified diseases classified elsewhereDementia in other diseases classified elsewhereDementia in Alzheimer disease
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06347315
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06347315 through Pure Global AI's free database. This phase not specified trial is sponsored by Société des Produits Nestlé (SPN) and is currently Not yet recruiting. The study focuses on Mild Cognitive Impairment. Target enrollment is 380 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.